Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Antituberculosis drugs can cause severe skin reactions, requiring careful diagnosis and treatment.

Early genetic testing and JAK inhibitors can help treat systemic inflammation in SAVI patients.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

Sintilimab treatment caused hair loss but led to complete tumor remission.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Incretin-based drugs for obesity often cause gastrointestinal issues, with tirzepatide having the most reports.

New inhibitors may reduce gut toxicity from cancer drugs.

Certain drugs like Dutasteride and Finasteride might help fight SARS-CoV-2 by increasing levels of a steroid called DHEA, which can protect the heart and increase nitric oxide to counteract the virus.

The Blood Glucose Management Service improved patient safety and outcomes in managing blood sugar in hospitalized patients.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

The framework helps predict adverse effects of blood thinners, improving drug selection for atrial fibrillation.

Manipulating 5α-reductase type 2 can affect liver fat production and glucocorticoid effects.

Some oral medications may help treat central serous chorioretinopathy, especially eplerenone, but more research is needed.

Oral isotretinoin effectively treated a young girl's scalp condition after other treatments failed.

Genetic changes in specific proteins contribute to hair loss in some women of African descent.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Some natural compounds from Iris plants can block enzymes related to certain disorders, with a few affecting both targeted enzymes.

Encapsulating hair loss drugs in cyclodextrins improves their solubility and reduces scalp irritation.

Some blood pressure medications are linked to a higher risk of skin cancer.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

Finasteride effectively inhibits the enzyme steroid 5 alpha-reductase II.

Secukinumab reduces immune activity in hidradenitis suppurativa skin.

Blocking DKK1 with siRNA can improve hair growth.

No single treatment is clearly effective for central serous chorioretinopathy.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

A patient with total hair loss developed vitiligo after using a treatment called DCP.

Farudodstat may effectively treat alopecia areata without harmful side effects.

Certain mutations in the H6PD gene cause Cortisone Reductase Deficiency by affecting hormone production.